Postmenopausal osteoporosis is associated with the regulation of SP, CGRP, VIP, and NPY.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Postmenopausal osteoporosis is associated with the regulation of SP, CGRP, VIP, and NPY.
- Published In:
- Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 104, 742-750 (2018)
- Authors:
- Liu, Xiaoguang, Liu, Hengrui, Xiong, Yingquan, Yang, Li, Wang, Chaopeng, Zhang, Ronghua, Zhu, Xiaofeng
- Database ID:
- RPEP-03786
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03786APA
Liu, Xiaoguang; Liu, Hengrui; Xiong, Yingquan; Yang, Li; Wang, Chaopeng; Zhang, Ronghua; Zhu, Xiaofeng. (2018). Postmenopausal osteoporosis is associated with the regulation of SP, CGRP, VIP, and NPY.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 104, 742-750. https://doi.org/10.1016/j.biopha.2018.04.044
MLA
Liu, Xiaoguang, et al. "Postmenopausal osteoporosis is associated with the regulation of SP, CGRP, VIP, and NPY.." Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018. https://doi.org/10.1016/j.biopha.2018.04.044
RethinkPeptides
RethinkPeptides Research Database. "Postmenopausal osteoporosis is associated with the regulatio..." RPEP-03786. Retrieved from https://rethinkpeptides.com/research/liu-2018-postmenopausal-osteoporosis-is-associated
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.